March

  • SOMAÍ merchandise can be found in Germany: Modern oral options
  • SOMAÍ acquired RPK Biopharma: enhanced capabilities, non-irradiated hashish cultivars, and Cookies strains
  • SOMAÍ enters the UK market with the distribution settlement with Develop Pharma; the primary merchandise are hitting the cabinets
  • SOMA raised 4 million euros
  • In vivo and in vitro research Worldwide conferences: Australia, Thailand, Portugal and extra

March went nice, and we wish to share the most recent achievements and plans for the following month. Our first line of merchandise is now accessible to sufferers, as now we have taken step one to overcome the worldwide medicinal hashish market.

In March, SOMAÍ Oral Options has turn out to be obtainable in Germany on prescription for sufferers on the Grünhorn Pharmacy and thru the most important hashish community canymed GmbH for pharmacies all through Germany. With the long run improvement of the German rules for extracts, we hope to quickly make much more revolutionary merchandise from our big selection accessible to medical doctors and sufferers.

This product line is just the start of our international launch of the widest portfolio of medicinal hashish, together with Proprietary Oral Resolution Formulations, Oral Spray Strains, Delicate Gel Capsules, Inhalation Oil Cartridges, and plenty of extra to reply to evolving affected person wants. At SOMAÍ Prescription drugs, our major purpose is to revolutionize the worldwide medicinal hashish markets by offering distinctive merchandise that meet the various wants of sufferers.

One of many details of this month is The acquisition by SOMAÍ of RPK Biopharma (Holigen). The corporate we bought has a 25,000 sq. foot EU-GMP licensed cultivation facility in Sintra devoted to the cultivation of premium high-THC hashish flowers. This strategic step not solely permits us to cowl the wants of the market premium hashish cultivars, not irradiated but in addition to offer sufferers strains of Cookies high-in-demand. This funding will considerably speed up SOMAÍ's international management, enhancing our Firm's skill to ship a portfolio of revolutionary differentiated cannabinoid merchandise to satisfy the wants of sufferers worldwide. The acquisition will increase SOMAÍ's capability with the most effective cultivation, manufacturing and distribution belongings, making it one of many few verticals within the EU capable of meet the various necessities of the quickly rising European hashish markets.

In March, SOMAÍ Prescription drugs launched the UK to the extra complete portfolio of hashish merchandise after a distribution enterprise GROW® Pharma. Underneath the two-year settlement, SOMAÍ will create entry to its portfolio of differentiated cannabinoid-containing merchandise for all UK-based clinics and medical hashish prescribers, utilizing Develop Pharma's in depth distribution community .

After the second, SOMAÍ Prescription drugs has raised 4 million euros, additional increasing our capabilities. George Bellow, co-founder and Managing Companion: “At present marks one other important stage in our journey as we’re proud to announce the profitable elevating of an extra funding of 4 million euros. This reaffirms our dedication to rising each organically and thru mergers and acquisitions.” At SOMAÍ, we consider that funding in Analysis and Improvement is vital to advancing the trade and offering higher assist to sufferers with numerous well being situations. Our group continues to create revolutionary new formulations that may utterly redefine the panorama of the medical hashish sector. As well as, we’re at the moment working a number of pharmacokinetic, dwell and in vitro research generate extra information for our merchandise.

SOMAÍ Prescription drugs was very energetic within the international area, collaborating in occasions across the globe: Thailand, Australia and Portugal. On the finish of February, we attended the Hashish Enterprise Asia-Pacific 2024that occurred in Bangkok, Thailand. Michael Sassano took the primary stage and shared the corporate's imaginative and prescient to create next-generation merchandise which might be thought-about the gold requirements of the market. Later, we have been honored to be the official Companion of the Gala Dinner on the ACannabis Convention in Melbourne, Australia, and to satisfy many proficient, passionate Australian medical doctors, pharmacists, and trade professionals who’re shifting the trade ahead. On the finish of March, SOMAÍ sponsored Third Nationwide Convention on Medicinal Hashishorganized by the OPCM-Portuguese Observatory of Medicinal Hashish in Coimbra, Portugal.

SOMAÍ is on the forefront of scientific analysis and improvement and understands the significance of advancing the trade to offer extra sufferers with a greater and more healthy life.


April 2024

In April, our international attain will broaden additional. From the preliminary launch in Germany, now we have our personal first line of Oral options with completely different concentrations of THC and CBD obtainable to sufferers within the Australian and UK markets. SOMAÍ has over 86 stabilized extract SKUs and constantly produces new superior product strains each month for hashish markets all over the world. Our subsequent era Oral Resolution line, produced in March, is able to ship throughout the subsequent month. Our merchandise cowl the evolving wants of all sufferers, from premium high quality hashish flower Cookies to revolutionary completed dosage types. Our formulations are made with precision, purity and style and symbolize our dedication to offering sufferers with tailored medicinal hashish options. Our strong and improved tasting product portfolio is about to evolve with proprietary terpene taste profiles, promising to revolutionize present product strains.

In April, the SOMAÍ group will attend the Worldwide Hashish Enterprise Convention InternationalCBC, which is able to happen on April 16-17 in Berlin. If you’re occupied with exploring potential collaborations with SOMAÍ Prescription drugs, don’t hesitate to schedule a gathering by reaching good day@somaipharma.eu.

Prepare for the launch of our newest, plus superior product line each month – keep tuned for the thrill! We create merchandise for at this time, tomorrow and past.


Newest articles from our CEO, Michael Sassano

Source link